PRESS RELEASE published on 04/10/2024 at 18:16, 7 months 12 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces purchase and cancellation of 150,000 ordinary shares as part of buy-back program, with details of the transaction prices London Stock Exchange Ordinary Shares Share Buyback Cancellation Funding Circle Plc
BRIEF published on 04/09/2024 at 18:15, 7 months 13 days ago Funding Circle Plc Executes Share Buy-Back, Announces Share Cancellation Share Buy-back London Stock Exchange Numis Securities Limited Funding Circle Plc Share Cancellation
PRESS RELEASE published on 04/09/2024 at 18:10, 7 months 13 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces purchase of 225,000 ordinary shares for cancellation at prices ranging from 45.50p to 47.00p per share on London Stock Exchange London Stock Exchange Share Purchase Funding Circle Plc Share Cancellation Buy-back
BRIEF published on 04/09/2024 at 13:32, 7 months 13 days ago Funding Circle Plc Announces Change in Major Holdings Voting Rights Major Holdings Regulatory Announcement Funding Circle Zedra Trust Company
PRESS RELEASE published on 04/09/2024 at 13:27, 7 months 13 days ago Funding Circle Plc: Notification of Major Holdings Notification of major holdings by Zedra Trust Company (Guernsey) for Funding Circle Plc. Voting rights crossed 3.90% threshold on 9th April 2024. Regulatory announcement issued in London, UK Voting Rights Major Holdings Notification Regulatory Announcement Funding Circle Plc
BRIEF published on 04/08/2024 at 18:19, 7 months 14 days ago Funding Circle Plc Completes Share Buyback Transaction Share Buyback Investment Stock Market Financial Regulation Funding Circle
PRESS RELEASE published on 04/08/2024 at 18:14, 7 months 14 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces the purchase and cancellation of 109,681 of its ordinary shares, part of its buy-back program, on the London Stock Exchange London Stock Exchange Ordinary Shares Purchase Cancellation Funding Circle Plc
BRIEF published on 04/08/2024 at 16:13, 7 months 14 days ago Funding Circle Plc Announces Share Option Awards to Top Executives Market Abuse Regulation Corporate Governance Funding Circle Plc Share Options Executive Awards
PRESS RELEASE published on 04/08/2024 at 16:08, 7 months 14 days ago Funding Circle Plc: DSH-Director/PDMR Shareholding* Funding Circle Plc granted Chief Executive Officer Lisa Jacobs and Chief Financial Officer Oliver White awards of nil cost options over ordinary shares PDMR Shareholding Funding Circle Plc Director DSH
BRIEF published on 04/05/2024 at 18:23, 7 months 17 days ago Funding Circle Plc Announces Share Buyback and Cancellation Share Buyback Financial Sector Stock Market Share Cancellation Funding Circle
Published on 11/22/2024 at 23:55, 3 hours 34 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 3 hours 59 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 4 hours 24 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 4 hours 59 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 9 hours 14 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 9 hours 35 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 10 hours 33 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 11 hours 29 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 1 day 20 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 8 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 9 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 9 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
